Assessment of the interplay between blood and skin vascular abnormalities in adult Purpura fulminans

American Journal of Respiratory and Critical Care Medicine

Volumn 188, Issue 6, 2013, Pages 684-692

  Lerolle, Nicolas ^a   Carlotti, Agnes ^b   Melican, Keira ^c   Aubey, Flore ^c   Pierrot, Marc ^a   Diehl, Jean Luc ^b   Caille, Vincent ^d   Hékimian, Guillaume ^e   Gandrille, Sophie ^b   Mandet, Chantal ^c   Bruneval, Patrick ^b   Dumenil, Guillaume ^c   Borgel, Delphine ^d  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c INSERM   (France)

^d HÔPITAL AMBROISE PARÉ   (France)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

Endothelium; Intensive care unit; Purpura fulminans; Sepsis

Indexed keywords

ACTIVATED PROTEIN C; ADRENALIN; ANTICOAGULANT AGENT; CD31 ANTIGEN; ENDOTHELIAL PROTEIN C RECEPTOR; HYPERTENSIVE FACTOR; NORADRENALIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOMODULIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CLINICAL ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM LESION; ESCHERICHIA COLI INFECTION; FEMALE; FULMINATING PURPURA; HEMATOLOGIC DISEASE; HEMOSTASIS; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; MALE; MENINGOCOCCOSIS; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; PURPURA; SEPSIS; SKIN BIOPSY; SKIN BLOOD FLOW; SKIN DEFECT; SKIN NECROSIS; THROMBOSIS; VASODILATATION;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BIOPSY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSPECTIVE STUDIES; PURPURA FULMINANS; SEPSIS; SKIN; THROMBOMODULIN; THROMBOSIS; VASCULAR MALFORMATIONS;

EID: 84884628993     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201302-0228OC     Document Type: Article

References (26)

1. Davis M D P, Dy KM, Nelson S. Presentation and outcome of purpura fulminans associated with peripheral gangrene in 12 patients at Mayo Clinic. J Am Acad Dermatol 2007;57:944-956.
2. Vincent J-L, Nadel S, Kutsogiannis DJ, Gibney R T N, Yan SB, Wyss VL, Bailey JE, Mitchell CL, Sarwat S, Shinall SM, et al. Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. Crit Care 2005;9:R331-R343.
3. Buysse C M P, Oranje AP, Zuidema E, Hazelzet JA, Hop W C J, Diepstraten AF, Joosten K F M. Long-term skin scarring and orthopaedic sequelae in survivors of meningococcal septic shock. Arch Dis Child 2009;94:381-386.
4. Kravitz GR, Dries DJ, Peterson ML, Schlievert PM. Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 2005;40:941-947.
5. Hayes MA, Yau EH, Hinds CJ, Watson JD. Symmetrical peripheral gangrene: association with noradrenaline administration. Intensive Care Med 1992;18:433-436.
6. Dünser MW, Mayr AJ, Tür A, Pajk W, Barbara F, Knotzer H, Ulmer H, Hasibeder WR. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. Crit Care Med 2003;31:1394-1398.
7. Fourrier F, Leclerc F, Aidan K, Sadik A, Jourdain M, Tournoys A, Noizet O. Combined antithrombin and protein C supplementation in meningococcal purpura fulminans: a pharmacokinetic study. Intensive Care Med 2003;29:1081-1087.
8. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001;345:408-416.
9. Harrison OB, Robertson BD, Faust SN, Jepson MA, Goldin RD, Levin M, Heyderman RS. Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo. Infect Immun 2002;70:5193-5201.
10. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
11. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001;86:1327-1330.
12. Mairey E, Genovesio A, Donnadieu E, Bernard C, Jaubert F, Pinard E, Seylaz J, Olivo-Marin J-C, Nassif X, Duménil G. Cerebral microcirculation shear stress levels determine Neisseria meningitidis attachment sites along the blood-brain barrier. J Exp Med 2006;203:1939-1950.
13. Dhainaut J-F, Yan SB, Joyce DE, Pettilä V, Basson B, Brandt JT, Sundin DP, Levi M. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2004;2:1924-1933.
14. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P. Septic shock, multiple organ failure, and disseminated intravascular coagulation: compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992;101:816-823.
15. Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, Cariou A, Um SL, Utterback B, Laterre P-F, Dhainaut J-F; PROWESS Sepsis Study Group. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care 2004;8:R82-R90.
16. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003;101:3765-3777.
17. Lerolle N, Nochy D, Guérot E, Bruneval P, Fagon J-Y, Diehl J-L, Hill G. Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med 2010;36:471-478.
18. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999;27:1230-1251.
19. Leone M, Boutière B, Camoin-Jau L, Albanèse J, Horschowsky N, Mège J-L, Martin C, Dignat-George F. Systemic endothelial activation is greater in septic than in traumatic-hemorrhagic shock but does not correlate with endothelial activation in skin biopsies. Crit Care Med 2002;30:808-814.
20. Mutunga M, Fulton B, Bullock R, Batchelor A, Gascoigne A, Gillespie JI, Baudouin SV. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 2001;163:195-200.
21. Reinhart K, Bayer O, Brunkhorst F, Meisner M. Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med 2002;30(5 Suppl):S302-S312.
22. De Backer D, Creteur J, Preiser J-C, Dubois M-J, Vincent J-L. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002;166:98-104.
23. Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885-891.
24. Staquet P, Lemee L, Verdier E, Bonmarchand G, Laudenbach V, Michel C, Lemeland J-F, Marret S, Blanc T. Detection of Neisseria meningitidis DNA from skin lesion biopsy using real-time PCR: usefulness in the aetiological diagnosis of purpura fulminans. Intensive Care Med 2007;33:1168-1172.
25. Guarner J, Greer PW, Whitney A, Shieh W-J, Fischer M, White EH, Carlone GM, Stephens DS, Popovic T, Zaki SR. Pathogenesis and diagnosis of human meningococcal disease using immunohistochemical and PCR assays. Am J Clin Pathol 2004;122:754-764.
26. Melican K, Michea Veloso P, Martin T, Bruneval P, Duménil G. Adhesion of Neisseria meningitidis to dermal vessels leads to local vascular damage and purpura in a humanized mouse model. PLoS Pathog 2013;9:e1003139.